Literature DB >> 10490659

The JIP group of mitogen-activated protein kinase scaffold proteins.

J Yasuda1, A J Whitmarsh, J Cavanagh, M Sharma, R J Davis.   

Abstract

Activation of the c-Jun NH(2)-terminal kinase (JNK) group of mitogen-activated protein (MAP) kinases is mediated by a protein kinase cascade. This signaling mechanism may be coordinated by the interaction of components of the protein kinase cascade with scaffold proteins. The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates signaling by the mixed-lineage kinase (MLK)-->MAP kinase kinase 7 (MKK7)-->JNK pathway. The scaffold proteins JIP1 and JIP2 interact to form oligomeric complexes that accumulate in peripheral cytoplasmic projections extended at the cell surface. The JIP proteins function by aggregating components of a MAP kinase module (including MLK, MKK7, and JNK) and facilitate signal transmission by the protein kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490659      PMCID: PMC84717          DOI: 10.1128/MCB.19.10.7245

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Selective interaction of JNK protein kinase isoforms with transcription factors.

Authors:  S Gupta; T Barrett; A J Whitmarsh; J Cavanagh; H K Sluss; B Dérijard; R J Davis
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Dimerization of Ste5, a mitogen-activated protein kinase cascade scaffold protein, is required for signal transduction.

Authors:  D Yablonski; I Marbach; A Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

3.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

4.  The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.

Authors:  C Y Kuan; D D Yang; D R Samanta Roy; R J Davis; P Rakic; R A Flavell
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

5.  The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye.

Authors:  J R Riesgo-Escovar; M Jenni; A Fritz; E Hafen
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

6.  A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila.

Authors:  H K Sluss; Z Han; T Barrett; D C Goberdhan; C Wilson; R J Davis; Y T Ip
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

7.  Signal transduction by tumor necrosis factor mediated by JNK protein kinases.

Authors:  H K Sluss; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun.

Authors:  I Sánchez; R T Hughes; B J Mayer; K Yee; J R Woodgett; J Avruch; J M Kyriakis; L I Zon
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

9.  JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation.

Authors:  T Kallunki; B Su; I Tsigelny; H K Sluss; B Dérijard; G Moore; R Davis; M Karin
Journal:  Genes Dev       Date:  1994-12-15       Impact factor: 11.361

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  154 in total

Review 1.  Signaling by fibroblast growth factors: the inside story.

Authors:  M Goldfarb
Journal:  Sci STKE       Date:  2001-10-30

Review 2.  Bromodomain motifs and "scaffolding"?

Authors:  G V Denis
Journal:  Front Biosci       Date:  2001-09-01

3.  A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation.

Authors:  Y Levkovitz; J M Baraban
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

4.  A Stat3-interacting protein (StIP1) regulates cytokine signal transduction.

Authors:  R G Collum; S Brutsaert; G Lee; C Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons.

Authors:  E T Coffey; V Hongisto; M Dickens; R J Davis; M J Courtney
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

6.  Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.

Authors:  Harry A Quigley; Frances E Cone; Scott E Gelman; Zhiyong Yang; Janice L Son; Ericka N Oglesby; Mary E Pease; Donald J Zack
Journal:  Exp Eye Res       Date:  2011-01-25       Impact factor: 3.467

7.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

8.  A new identity for MLK3 as an NIMA-related, cell cycle-regulated kinase that is localized near centrosomes and influences microtubule organization.

Authors:  Katherine I Swenson; Katharine E Winkler; Anthony R Means
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

Review 9.  Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

10.  A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria.

Authors:  Carolyn Wiltshire; Masato Matsushita; Satoshi Tsukada; David A F Gillespie; Gerhard H W May
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.